Papaverinum Hydrochloricum Wzf (Papaverine Hydrochloride)

Papaverine Hydrochloride, the active ingredient in Papaverinum Hydrochloricum Wzf, is a vasodilator presented as a sterile solution for intravenous use. It relaxes smooth muscle and is employed to alleviate vasospastic conditions in adult patients. It is classified as a phosphodiesterase inhibitor and is used primarily in cardiovascular and gastrointestinal settings.

GNH USA supplies Papaverinum Hydrochloricum Wzf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring quality and regulatory conformity through reliable logistics.

Papaverine Hydrochloride acts as a smooth‑muscle relaxant and vasodilator, addressing conditions characterized by spasm of vascular or gastrointestinal smooth muscle.

- Coronary artery spasm: relief of vasospastic angina and improvement of coronary blood flow. - Intestinal colic: reduction of gastrointestinal smooth‑muscle spasm, easing abdominal pain. - Peripheral vascular disease: enhancement of limb blood flow by relaxing arterial smooth muscle.

Papaverine Hydrochloride may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Flushing: transient redness of the skin. - Headache: mild to moderate intensity. - Hypotension: drop in blood pressure, especially with rapid infusion. - Nausea: occasional gastrointestinal upset. - Dizziness: sensation of light‑headedness. - Abdominal discomfort: mild cramping.

Serious or Rare Side Effects: - Severe hypotension: profound blood pressure fall requiring intervention. - Allergic reaction: rash, itching, or urticaria. - Anaphylaxis: life‑threatening systemic hypersensitivity. - Cardiac arrhythmia: irregular heart rhythm. - Hepatic dysfunction: elevated liver enzymes. - Stevens‑Johnson syndrome: severe skin eruption.

Before using Papaverine Hydrochloride, clinicians should consider several safety measures to minimize risk.

- Cardiovascular status: monitor blood pressure and heart rate during administration. - Renal impairment: assess kidney function and adjust therapy if necessary. - Hepatic disease: use with caution in patients with liver dysfunction. - Pregnancy and lactation: avoid unless benefits outweigh potential risks. - Concomitant vasodilators: evaluate for additive hypotensive effects. - Store at ambient temperature: keep in original container, protect from moisture and light.

Papaverine Hydrochloride can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Other vasodilators (e.g., nitroglycerin): risk of severe hypotension. - Alpha‑adrenergic blockers: additive blood pressure lowering. - Antihistamines with anticholinergic activity: may increase tachycardia.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt compensatory tachycardia. - Calcium channel blockers: potential for enhanced vasodilation. - MAO inhibitors: possible hypertensive episodes.